Rapid Influenza Diagnostic Tests Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Influenza
Market Overview:
Rapid influenza diagnostic tests are point of care medical devices used for the
rapid detection of influenza virus in patient sample such as nasopharyngeal
swab. These tests allow rapid diagnosis of influenza infection within 15-30
minutes, helping medical professionals treat patients faster. The advantages of
rapid tests over conventional lab tests include quick results, ease of use at
physician offices or clinics, and high accuracy.
The Rapid Influenza Diagnostic Tests Market was valued at US$ 1.29 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023-2030, as highlighted in a new report published by CoherentMI.
Market Key Trends:
One of the key trends driving growth of the rapid influenza diagnostic tests
market include rising prevalence of influenza. The influenza viruses are
continuously mutating and evolving, leading to epidemics almost every year.
According to the Centers for Disease Control and Prevention, on an average
41,000 people die every year in the United States due to influenza-related
complications. With the influenza virus mutating rapidly, rapid diagnostic
tests play a crucial role in early diagnosis and timely intervention, thereby
supporting market growth. The availability of rapid tests with high accuracy,
quick results, and user-friendly design have further increased their adoption
globally.
Global Rapid Influenza Diagnostic Tests
Market Segmentation
By
Test Type
o
Rapid
Molecular Assays
o
Rapid
Immunoassays
o
Others
By
Influenza Type
o
Influenza
type A
o
Influenza
type B
o
Influenza
type C
o
Others
By
Specimen Type
o
Nasopharyngeal
swab
o
Nasal
swab
o
Throat
swab
o
Others
By
End User
o
Diagnostic
Laboratories
o
Hospitals
& Clinics
o
Research
Institutes
o
Others
By
Region
o
North
America
o
Europe
o
Asia
Pacific
o
Latin
America
o
Middle
East
o
Africa
Porter’s
Analysis
Threat of New Entrants: Low barriers
to enter rapid influenza diagnostic tests market such as low cost of manufacturing.
However, established companies have strong brand recognition and distribution
networks.
Bargaining Power Of Buyers: Moderate
as large diagnostic service providers and hospitals can negotiate lower prices.
However, necessity of rapid diagnosis gives buyers less influence over prices.
Bargaining Power of Suppliers: Low
as raw materials required are commodity chemicals and availability of
substitute suppliers limits influence on prices.
Threat of New Substitutes: Low as
rapid diagnostic tests have benefits over conventional methods and new
substitutes require significant R&D investment.
Competitive Rivalry: High among
existing major companies like Quidel Corporation, Becton Dickinson trying to
launch new products and target market share.
SWOT Analysis
Strengths: Rapid diagnosis helps
speed up treatment. Sensitivity and specificity help rule out false
negatives/positives.
Weaknesses: Require specialized
equipment and skilled staff. Higher costs compared to conventional methods.
Opportunities: Increasing flu
outbreaks and need for fast diagnosis present market expansion opportunities.
Growth in developing countries provides untapped potential.
Threats: Stringent regulatory
approvals and reimbursement policies pose challenges. Threat from alternative
diagnostic methods.
Key Takeaways
The global Rapid
Influenza Diagnostic Tests Market Size is expected to witness high
growth at a CAGR of 7.9% over the forecast period, due to increasing prevalence
of influenza infections globally. The market was valued at US$ 1.29 billion in
2023.
North America currently dominates the rapid influenza diagnostic tests market
owing to growing geriatric population, availability of advanced healthcare
infrastructure and dominant presence of key players in the region. However,
Asia Pacific is expected to exhibit the fastest growth over the coming years
supported by increasing healthcare investments, economic growth and rising
occurrence of influenza cases.
Key players operating in the rapid
influenza diagnostic tests market are Quidel
Corporation, Becton Dickinson, Thermo Fisher Scientific, Abbott Laboratories,
F. Hoffmann-La Roche, DiaSorin, Luminex Corporation, Meridian Bioscience,
GenMark Diagnostics, Sekisui Diagnostics, and Virax Biolabs. Leading
companies are focusing on new product launches and geographic expansion
strategies to consolidate their market position.
Reasons to Purchase Rapid Influenza
Diagnostic Tests Market Report:
1. Enhance the decision-making
process by understanding the strategies that underpin commercial interest with
respect to products, segmentation, and industry verticals.
2. Develop/modify business expansion
plans by using substantial growth offerings in developed and emerging markets.
3. Save and reduce time carrying out
entry-level research by identifying the growth, size, leading players, and
segments in the Rapid Influenza Diagnostic Tests Market.
FAQ’s
Q.1 What will the market
development pace of the Rapid Influenza Diagnostic Tests Market?
Q.2 What are the sales,
revenue, and price analysis of the top players of the Rapid Influenza
Diagnostic Tests Market?
Get more insights on this topic:
https://www.marketwebjournal.com/rapid-influenza-diagnostic-tests-market-growth-and-forecast-analysis/
Comments
Post a Comment